Trizahype 35 MR Tablet
Marketer
Fibovil Pharmaceuticals Pvt Ltd
Salt Composition
Trimetazidine (35mg)
Overview Trizahype 35 MR Tablet
CardioGuard 35 MR is a medication used to manage angina pectoris, a type of chest pain stemming from heart conditions. This medicine works to prevent future angina episodes, but it won't alleviate an attack already in progress. It can be administered independently or alongside other therapies. As directed by your physician, take CardioGuard 35 MR consistently, with or without food, at the same time each day. Dosage frequency will be determined and potentially adjusted by your doctor based on its effectiveness. Continuous use, even when feeling well, is vital for optimal results and future cardiac health. Discontinuation may lead to a recurrence of chest pain. Adopting a healthier lifestyle – including smoking cessation, moderate alcohol consumption, a balanced diet, regular physical activity, and stress management – complements this treatment. Potential side effects include, but are not limited to: lightheadedness, headache, stomach upset, diarrhea, indigestion, nausea, vomiting, skin rash, itching, hives, and fatigue. Report any persistent or bothersome side effects to your physician. This medication may not be appropriate for everyone. Individuals with liver or kidney impairments, pregnant or breastfeeding women, and those on other medications must disclose this information to their doctor before commencing treatment.
Primary Ingredients of Trizahype 35 MR Tablet
The provided text is "undefined," therefore no rewriting is possible.
Uses of Trizahype 35 MR Tablet
Managing Chest Pain Associated with Coronary Artery Disease
Major Benefits of Trizahype 35 MR Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the Trizahype 35 MR Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with a meal.
Common Side effects of Trizahype 35 MR Tablet:
- Dizziness
- Headache
- Nausea
- Vomiting
- Weakness
- Rash
- Abdominal pain
- Indigestion
- Itching
- Diarrhea
- Hives
How to use Trizahype 35 MR Tablet:
Follow your physician's instructions precisely regarding dosage and treatment length for Trizahype 35 MR Tablet. Ingest the tablet whole; do not crush, chew, or break it. Administer this medication with food.
How Trizahype 35 MR Tablet works:
Trizahype 35 MR tablets offer anti-anginal benefits by altering cardiac metabolism. This medication reduces the heart's oxygen demand through a metabolic shift from fatty acids to glucose, thereby enhancing cardiac efficiency.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Trizahype 35 MR Tablet and alcohol may result in significant sedation.
PregnancyCONSULT YOUR DOCTOR
Data on Trizahype 35 MR Tablet use in pregnancy is currently lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on Trizahype 35 MR Tablet use while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving may be unsafe while taking Trizahype 35 MR Tablet due to potential side effects such as drowsiness, blurred vision, and dizziness. Avoid operating vehicles if you experience these symptoms.
KidneyCAUTION
Patients with kidney impairment should use Trizahype 35 MR Tablet cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in individuals with severe kidney disease.
LiverCONSULT YOUR DOCTOR
Data on Trizahype 35 MR Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Trizahype 35 MR Tablet :
Should you forget a Trizahype 35 MR Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Trizahype 35 MR Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzylamines |
| Developing Habits | No. |
| Type of Therapy | HEART |
| Behavior Class | Fatty acid regulator and sodium channel inhibitor |



